Asset Details
Do you wish to reserve the book?
The CCR5 Patent(s)
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The CCR5 Patent(s)
Do you wish to request the book?
The CCR5 Patent(s)
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Book Chapter
The CCR5 Patent(s)
2015
Overview
Although gene patents had been awarded for nearly a decade before its existence, the Human Genome Project (HGP) (1990 to 2003) brought human genes and intellectual property issues to the fore. An international collaboration that was started and led by the United States, the HGP had an ambitious goal—to sequence the entire human genome, which is made up of 3 billion base pairs of DNA.¹ Planning started in 1984 with the work of Charles DeLisi, a physicist and director of the Office Health and Environment at the Department of Energy, and Robert Sinsheimer, a Caltech molecular biologist and chancellor
